269 related articles for article (PubMed ID: 26394842)
1. Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease.
Pienaar IS; Gartside SE; Sharma P; De Paola V; Gretenkord S; Withers D; Elson JL; Dexter DT
Mol Neurodegener; 2015 Sep; 10():47. PubMed ID: 26394842
[TBL] [Abstract][Full Text] [Related]
2. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
[TBL] [Abstract][Full Text] [Related]
3. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
Elson JL; Yates A; Pienaar IS
Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
[TBL] [Abstract][Full Text] [Related]
4. Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
Xiao H; Li M; Cai J; Li N; Zhou M; Wen P; Xie Z; Wang Q; Chang J; Zhang W
Neurosci Lett; 2017 Oct; 659():92-98. PubMed ID: 28803956
[TBL] [Abstract][Full Text] [Related]
5. Gait improvement by high-frequency stimulation of the subthalamic nucleus in Parkinsonian mice is not associated with changes of the cholinergic system in the pedunculopontine nucleus.
Witzig VS; Alosaimi F; Temel Y; Schulz JB; Jahanshahi A; Tan SKH
Neurosci Lett; 2023 Apr; 802():137134. PubMed ID: 36801348
[TBL] [Abstract][Full Text] [Related]
6. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
7. c-Fos expression after deep brain stimulation of the pedunculopontine tegmental nucleus in the rat 6-hydroxydopamine Parkinson model.
Saryyeva A; Nakamura M; Krauss JK; Schwabe K
J Chem Neuroanat; 2011 Nov; 42(3):210-7. PubMed ID: 21855627
[TBL] [Abstract][Full Text] [Related]
8. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
Elson JL; Kochaj R; Reynolds R; Pienaar IS
Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
[TBL] [Abstract][Full Text] [Related]
9. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
Pienaar IS; van de Berg W
Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
[TBL] [Abstract][Full Text] [Related]
10. Deep brain stimulation of different pedunculopontine targets in a novel rodent model of parkinsonism.
Gut NK; Winn P
J Neurosci; 2015 Mar; 35(12):4792-803. PubMed ID: 25810510
[TBL] [Abstract][Full Text] [Related]
11. Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model.
Rauch F; Schwabe K; Krauss JK
Behav Brain Res; 2010 Jun; 210(1):46-53. PubMed ID: 20138919
[TBL] [Abstract][Full Text] [Related]
12. Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model.
Alam M; Heissler HE; Schwabe K; Krauss JK
Exp Neurol; 2012 Jan; 233(1):233-42. PubMed ID: 22036687
[TBL] [Abstract][Full Text] [Related]
13. The effect of low frequency stimulation of the pedunculopontine tegmental nucleus on basal ganglia in a rat model of Parkinson's disease.
Park E; Song I; Jang DP; Kim IY
Neurosci Lett; 2014 Aug; 577():16-21. PubMed ID: 24928224
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic excitation from the pedunculopontine tegmental nucleus to the dentate nucleus in the rat.
Vitale F; Mattei C; Capozzo A; Pietrantoni I; Mazzone P; Scarnati E
Neuroscience; 2016 Mar; 317():12-22. PubMed ID: 26762800
[TBL] [Abstract][Full Text] [Related]
15. The Pedunculopontine Tegmental Nucleus is not Important for Breathing Impairments Observed in a Parkinson's Disease Model.
Miranda NC; Oliveira LM; Aquino YC; Moreira TS; Takakura AC
Neuroscience; 2023 Feb; 512():32-46. PubMed ID: 36690033
[TBL] [Abstract][Full Text] [Related]
16. Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [¹⁸F]fluoroethoxybenzovesamicol.
Cyr M; Parent MJ; Mechawar N; Rosa-Neto P; Soucy JP; Clark SD; Aghourian M; Bedard MA
Behav Brain Res; 2015 Feb; 278():107-14. PubMed ID: 25257103
[TBL] [Abstract][Full Text] [Related]
17. Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
Chambers NE; Coyle M; Sergio J; Lanza K; Saito C; Topping B; Clark SD; Bishop C
Eur J Neurosci; 2021 Apr; 53(8):2835-2847. PubMed ID: 33426708
[TBL] [Abstract][Full Text] [Related]
18. Deciphering midbrain mechanisms underlying prepulse inhibition of startle.
Fulcher N; Azzopardi E; De Oliveira C; Hudson R; Schormans AL; Zaman T; Allman BL; Laviolette SR; Schmid S
Prog Neurobiol; 2020 Feb; 185():101734. PubMed ID: 31863802
[TBL] [Abstract][Full Text] [Related]
19. The anterior and posterior pedunculopontine tegmental nucleus are involved in behavior and neuronal activity of the cuneiform and entopeduncular nuclei.
Jin X; Schwabe K; Krauss JK; Alam M
Neuroscience; 2016 May; 322():39-53. PubMed ID: 26880033
[TBL] [Abstract][Full Text] [Related]
20. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
